Indonesia
· Delayed Price · Currency is IDR PT Merck Tbk Statistics
Total Valuation
PT Merck Tbk has a market cap or net worth of IDR 1.71 trillion. The enterprise value is 1.65 trillion.
| Market Cap | 1.71T |
| Enterprise Value | 1.65T |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | Jun 7, 2024 |
Share Statistics
PT Merck Tbk has 448.00 million shares outstanding.
| Shares Outstanding | 448.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.65% |
| Float | 59.81M |
Valuation Ratios
The trailing PE ratio is 12.76.
| PE Ratio | 12.76 |
| Forward PE | n/a |
| PS Ratio | 1.83 |
| PB Ratio | 2.45 |
| P/FCF Ratio | 14.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.68, with an EV/FCF ratio of 14.14.
| EV / Earnings | 12.33 |
| EV / Sales | 1.77 |
| EV / EBITDA | 9.68 |
| EV / EBIT | 11.85 |
| EV / FCF | 14.14 |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 2.67.
| Current Ratio | 3.21 |
| Quick Ratio | 1.29 |
| Debt / Equity | 2.67 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.16 |
| Interest Coverage | 43.28 |
Financial Efficiency
Return on equity (ROE) is 19.09% and return on invested capital (ROIC) is 12.11%.
| Return on Equity (ROE) | 19.09% |
| Return on Assets (ROA) | 9.36% |
| Return on Capital (ROIC) | 12.11% |
| Revenue Per Employee | 2.48B |
| Profits Per Employee | 355.63M |
| Employee Count | 372 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.75% in the last 52 weeks. The beta is 0.58, so PT Merck Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -19.75% |
| 50-Day Moving Average | 3,898.00 |
| 200-Day Moving Average | 4,044.20 |
| Relative Strength Index (RSI) | 44.21 |
| Average Volume (20 Days) | 17,060 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Merck Tbk had revenue of IDR 934.43 billion and earned 134.07 billion in profits. Earnings per share was 299.27.
| Revenue | 934.43B |
| Gross Profit | 348.96B |
| Operating Income | 139.53B |
| Pretax Income | 146.21B |
| Net Income | 134.07B |
| EBITDA | 164.09B |
| EBIT | 139.53B |
| Earnings Per Share (EPS) | 299.27 |
Balance Sheet
The company has 77.19 billion in cash and 18.72 billion in debt, giving a net cash position of 58.47 billion or 130.52 per share.
| Cash & Cash Equivalents | 77.19B |
| Total Debt | 18.72B |
| Net Cash | 58.47B |
| Net Cash Per Share | 130.52 |
| Equity (Book Value) | 699.72B |
| Book Value Per Share | 1,561.87 |
| Working Capital | 509.24B |
Cash Flow
In the last 12 months, operating cash flow was 135.40 billion and capital expenditures -18.53 billion, giving a free cash flow of 116.87 billion.
| Operating Cash Flow | 135.40B |
| Capital Expenditures | -18.53B |
| Free Cash Flow | 116.87B |
| FCF Per Share | 260.87 |
Margins
Gross margin is 37.34%, with operating and profit margins of 14.93% and 14.35%.
| Gross Margin | 37.34% |
| Operating Margin | 14.93% |
| Pretax Margin | 15.65% |
| Profit Margin | 14.35% |
| EBITDA Margin | 17.56% |
| EBIT Margin | 14.93% |
| FCF Margin | 12.51% |
Dividends & Yields
This stock pays an annual dividend of 320.00, which amounts to a dividend yield of 8.38%.
| Dividend Per Share | 320.00 |
| Dividend Yield | 8.38% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 107.06% |
| Buyback Yield | n/a |
| Shareholder Yield | 8.38% |
| Earnings Yield | 7.83% |
| FCF Yield | 6.83% |
Stock Splits
The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.
| Last Split Date | Dec 21, 2015 |
| Split Type | Forward |
| Split Ratio | 20 |